Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
250
-
Total 13F shares, excl. options
-
19.7M
-
Shares change
-
+535K
-
Total reported value, excl. options
-
$3.59B
-
Value change
-
+$100M
-
Put/Call ratio
-
0.11
-
Number of buys
-
121
-
Number of sells
-
-104
-
Price
-
$182.28
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q4 2016
281 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q4 2016.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 250 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.7M shares
.
Largest 10 shareholders include ATLANTA CAPITAL MANAGEMENT CO L L C (1.78M shares), VANGUARD GROUP INC (1.61M shares), ACADIAN ASSET MANAGEMENT LLC (930K shares), ARIEL INVESTMENTS, LLC (887K shares), BlackRock Fund Advisors (873K shares), MORGAN STANLEY (840K shares), BlackRock Institutional Trust Company, N.A. (637K shares), STATE STREET CORP (538K shares), TimesSquare Capital Management, LLC (522K shares), and Corvex Management LP (487K shares).
This table shows the top 250 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.